Overall, our results suggest that the inducible activation of Kras upregulates transcription factors Ncoa3, pcJun and FoxM1, which, in turn, upregulate mucin expression in the pancreas, reflecting our findings that were first reported in the KC model. The gene discussed is KRAS; the disease is keratoconus.